US$ 23.38
semaglutide injection vs tirzepatide for Weight Loss: Which is Better? Tirzepatide vs. Semaglutide: Which Works
Description
But the news keeps getting better, with recent clinical trials in a wide range of chronic (long-term) conditions suggesting significant treatment benefits even when patients are normal weight and not diabetic

Lower side effect burden on the day of a test is simply more comfortable

GLP-1 is a weight loss peptide used to treat obesity

Mechanistically, GLP-1R activation appears to downregulate TNF- production via 1-adrenergic, -opioid, and -opioid receptor pathways (Wong et al., 2024)

While this is the licensed indication, it's important to note that NICE guidance (TA875) recommends more specific criteria for NHS use: typically for people with a BMI 35 kg/m (lower thresholds may apply for some ethnic groups) with at least one weight-related comorbidity, prescribed within specialist weight management services, and limited to a maximum treatment duration of 2 years
